(19)
(11) EP 1 372 626 A1

(12)

(43) Date of publication:
02.01.2004 Bulletin 2004/01

(21) Application number: 02713692.8

(22) Date of filing: 25.02.2002
(51) International Patent Classification (IPC)7A61K 31/155, A61K 31/522, A61K 38/03, A61K 38/04, A61K 38/13, A61K 38/16
(86) International application number:
PCT/US2002/005804
(87) International publication number:
WO 2002/067917 (06.09.2002 Gazette 2002/36)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 23.02.2001 US 792480

(71) Applicant: Cellgate Inc.
Sunnyvale, CA 94086 (US)

(72) Inventors:
  • ROTHBARD, Jonathan, B.
    Cupertino, CA 95014 (US)
  • WENDER, Paul, A.
    Menlo Park, CA 94025 (US)
  • MCGRANE, P., Leo
    Mountain View, CA 94040 (US)
  • SISTA, Lalitha, V.S.
    Sunnyvale, CA 94087 (US)
  • KIRSCHBERG, Thorsten, A.
    Mountain View, CA 94041 (US)

(74) Representative: Campbell, Patrick John Henry et al
J.A. Kemp & Co.,14 South Square,Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) COMPOSITIONS AND METHODS FOR ENHANCING DRUG DELIVERY ACROSS AND INTO OCULAR TISSUES